Vial

Vial is a next-generation biotech company advancing first and best-in-class biologics to treat unmet need in Immunology and Inflammation. The company pairs AI-driven drug discovery with automated, technology-enabled clinical trials, working across target discovery (identifying high-value therapeutic targets), molecule design (generating and optimizing molecular candidates), and experimental validation (high-throughput approaches to accelerate development). Its lead pipeline program is an IL-13 x TSLP bi-specific antibody in Phase 1. Vial was originally built as a tech-enabled contract research organization (CRO) focused on reimagining clinical trials, and was backed by General Catalyst. This profile is maintained in the API Evangelist network; as of this enrichment pass Vial publishes no public developer, API, or documentation surface.

Vial is profiled on the APIs.io network. Tagged areas include Company, Biotech, Life Sciences, Clinical Trials, and Drug Discovery.

🌐 Visit website 📡 Source on GitHub
10.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechLife SciencesClinical TrialsDrug DiscoveryImmunologyContract Research OrganizationArtificial Intelligence

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 10.8/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/vial: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Vial Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: vial
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/vial.png
name: Vial
description: Vial is a next-generation biotech company advancing first and best-in-class biologics to treat unmet need in
  Immunology and Inflammation. The company pairs AI-driven drug discovery with automated, technology-enabled clinical trials,
  working across target discovery (identifying high-value therapeutic targets), molecule design (generating and optimizing
  molecular candidates), and experimental validation (high-throughput approaches to accelerate development). Its lead pipeline
  program is an IL-13 x TSLP bi-specific antibody in Phase 1. Vial was originally built as a tech-enabled contract research
  organization (CRO) focused on reimagining clinical trials, and was backed by General Catalyst. This profile is maintained
  in the API Evangelist network; as of this enrichment pass Vial publishes no public developer, API, or documentation surface.
url: https://raw.githubusercontent.com/api-evangelist/vial/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotech
- Life Sciences
- Clinical Trials
- Drug Discovery
- Immunology
- Contract Research Organization
- Artificial Intelligence
apis: []
common:
- type: DomainSecurity
  url: security/vial-domain-security.yml
- type: Website
  url: https://vial.com
- type: PrivacyPolicy
  url: https://vial.com/privacy-notice/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1